Novigenix Collaborates with BioLizard to Develop AI-Based Diagnostic Algorithm for Detecting Colon Cancer

Novigenix Collaborates with BioLizard to Develop AI Based Diagnostic Algorithm for Detecting Colon Cancer

Shots:

  • BioLizard to develop an AI-based bioinformatics algorithm supporting the transition of its Immuno-Transcriptomic RT-PCR based product, Colox onto Novigenix’s LITOseek platform for early colon cancer detection as well as with other products under development
  • The collaboration involves BioLizard expertise in bioinformatics, machine learning, AI and data mining to co-develop the clinical diagnostic algorithm for Novigenix’s LITOseek platform
  • Novigenix’s LITOseek platform is a blood Immuno-Transcriptomic sequence platform, analyzing the gene expression modifications induced by the host as the response to triggers like onset of the cancer

Click here to­ read full press release/ article | Ref: Businesswire | Image: Novigenix